September 2, 2022 MP Corporate Presentation August 26, 2022 H1 2022 Corporate Highlights and Financials April 25, 2022 Kempen Conference Presentation March 16, 2022 Publication of full year results 2021 January 12, 2022 JP Morgan 40th Annual Virtual Healthcare Conference Presentation January 10, 2022 Ensovibep Clinical Results Call Presentation January 10, 2022 HC Wainwright Healthcare Conference Presentation December 15, 2021 Oncology Day 2021 Presentation November 17, 2021 MP Corporate Presentation October 20, 2021 Pre-clinical data of ensovibep, a multi-specific DARPin therapeutic with high potency against all frequent SARS-CoV-2 variants Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Next page next › Last page last »
October 20, 2021 Pre-clinical data of ensovibep, a multi-specific DARPin therapeutic with high potency against all frequent SARS-CoV-2 variants